Suppr超能文献

综述:临床精神病高危青少年阴性症状评估策略

A review of negative symptom assessment strategies in youth at clinical high-risk for psychosis.

机构信息

Department of Psychology, University of Georgia, Athens, GA, USA.

Department of Psychiatry, University of North Carolina, Chapel Hill, NC, USA.

出版信息

Schizophr Res. 2020 Aug;222:104-112. doi: 10.1016/j.schres.2020.04.019. Epub 2020 Jun 7.

Abstract

Studies attempting to deconstruct the heterogeneity of schizophrenia and the attenuated psychosis syndrome consistently find that negative symptoms are a core dimension that is distinct from other aspects of the illness (e.g., positive and disorganized symptoms). Negative symptoms are also highly predictive of poor community-based functional outcomes, suggesting they are a critical treatment target. Unfortunately, pharmacological and psychosocial treatments for negative symptoms have demonstrated limited effectiveness. To address this critical unmet therapeutic need, the NIMH sponsored a consensus development conference to delineate research priorities for the field and stimulate treatment development. A primary conclusion of this meeting was that next-generation negative symptom rating scales should be developed to address methodological and conceptual limitations of existing instruments. Although second-generation rating scales were developed for adults with schizophrenia, progress in this area has lagged behind for youth at clinical-high risk (CHR) for developing psychosis (i.e. those meeting criteria for a prodromal syndrome). Given that negative symptoms are highly predictive of the transition to diagnosable psychotic illness, enhancing our ability to detect negative symptoms in CHR youth is paramount. The current paper discusses conceptual and methodological limitations inherent to existing scales that assess negative symptoms in CHR youth. The theoretical and clinical implications of these limitations are evaluated. It is concluded that new scales specifically designed to assess negative symptoms in CHR youth are needed to accurately chart mental illness trajectories and determine when, where, and how to intervene. Recent efforts to develop next-generation measures designed specifically for CHR youth to meet this urgent need in the field are discussed. These new approaches offer significant progress for addressing issues inherent to earlier scales.

摘要

研究试图解构精神分裂症的异质性和缓解精神病综合征,一致发现阴性症状是一个核心维度,与疾病的其他方面(如阳性和紊乱症状)不同。阴性症状也高度预测不良的社区功能结局,表明它们是一个关键的治疗目标。不幸的是,针对阴性症状的药物治疗和心理社会治疗已被证明效果有限。为了解决这一关键的未满足的治疗需求,NIMH 赞助了一次共识发展会议,以划定该领域的研究重点并促进治疗的发展。这次会议的一个主要结论是,应该开发下一代阴性症状评定量表,以解决现有工具在方法学和概念上的局限性。尽管第二代评定量表是为成年精神分裂症患者开发的,但在该领域,针对有临床高风险(CHR)发展为精神病的青年的进展落后了(即符合前驱综合征标准的人)。鉴于阴性症状高度预测向可诊断的精神病转变,提高我们在 CHR 青年中检测阴性症状的能力至关重要。目前的论文讨论了评估 CHR 青年阴性症状的现有量表所固有的概念和方法学局限性。评估了这些局限性的理论和临床意义。结论是,需要专门设计用于评估 CHR 青年阴性症状的新量表,以准确描绘精神疾病轨迹,并确定何时、何地以及如何进行干预。本文还讨论了最近为满足该领域的迫切需求而专门为 CHR 青年开发下一代测量工具的努力。这些新方法为解决早期量表所固有的问题提供了重大进展。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验